Ketamine administration reduces limbic reactivity during emotional stimulation: 
An fMRI study in healthy subjects

Scheidegger, M; Grimm, S; Walter, M; Boeker, H; Boesiger, P; Seifritz, E; Henning, A

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Meeting Abstract

Ketamine administration reduces limbic reactivity during emotional stimulation: An fMRI study in healthy subjects

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

https://www.ismrm.org/12/Session65.htm
(Abstract)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Scheidegger, M., Grimm, S., Walter, M., Boeker, H., Boesiger, P., Seifritz, E., et al. (2012). Ketamine administration reduces limbic reactivity during emotional stimulation: An fMRI study in healthy subjects. In 20th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2012).

Cite as: https://hdl.handle.net/11858/00-001M-0000-0013-B750-9

Abstract

Many neuroimaging findings are compatible with the hypothesis that limbic hyperactivity during evaluation of emotional stimuli, combined with prefrontal hypoactivity, might cause negative emotional biases in patients suffering from major depressive disorder (MDD) and that this imbalance can be reversed by antidepressant drug treatment. Our findings show that in healthy subjects an antidepressant intravenous dose of ketamine reduces limbic reactivity in the amygdalo-hippocampal complex during an emotional processing task, which is in support of the hypothesis that pharmacologically modulating limbic neurocircuits might be an important therapeutic strategy to restore parts of the disrupted neurobehavioural homeostasis in MDD.